{"data":{"id":"us/21-cfr-314.201","jurisdiction":"us","citation":"21 CFR 314.201","heading":"Procedure for hearings.","body":"Parts 10 through 16 apply to hearings relating to new drugs under section 505 (d) and (e) of the act.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER D—DRUGS FOR HUMAN USE","PART 314—APPLICATIONS FOR FDA APPROVAL TO MARKET A NEW DRUG","Subpart E—Hearing Procedures for New Drugs"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"66e8db7b30f9f6c7105906f2b019e170bf02a1ab6a3a35a02b476da428b04bac","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-314.200","next":"us/21-cfr-314.235"},"notice":"GroundRules: Original legal text. Not legal advice."}